Adamas Pharmaceuticals Inc 4
4 · Adamas Pharmaceuticals Inc · Filed Aug 8, 2016
Insider Transaction Report
Form 4
MacPhee John A
Director
Transactions
- Award
Stock Option (Right to Buy)
2016-08-05+12,600→ 12,600 totalExercise: $13.68Exp: 2026-08-04→ Common Stock (12,600 underlying)
Footnotes (1)
- [F1]The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from August 5, 2016, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of each such date.